{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,18]],"date-time":"2026-11-18T16:07:23Z","timestamp":1795018043329,"version":"4.10.1"},"reference-count":36,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2023,5,22]],"date-time":"2023-05-22T00:00:00Z","timestamp":1684713600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2023,5,22]],"date-time":"2023-05-22T00:00:00Z","timestamp":1684713600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Cancer"],"abstract":"<jats:title>Abstract<\/jats:title><jats:p>This study presents the trends of age-standardised incidence and mortality rates of common cancers in Brunei Darussalam from 2011 to 2020. All cancer cases diagnosed among Brunei Darussalam citizens and permanent residents in the period 2011 to 2020 were included in the study. De-identified data were provided by the CanReg5 based BDCR, Ministry of Health Brunei Darussalam. The annual age-standardised incidence and mortality rates per 100,000 persons were standardised by the direct method using the World Health Organization (WHO) world standard population distribution. Joinpoint regression analyses were used to study the incidence and mortality trends of cancer in Brunei Darussalam over the 2011\u20132020 period. Trends were expressed as average annual percent change (AAPC) over 2011 to 2020, or annual percent change (APC) for a given time period. There were a total of 6,495 new cancer cases diagnosed and 3,359 death cases recorded from 2011 to 2020, in Brunei Darussalam. The five common cancers for males were colorectal, lung and bronchus, prostate, liver, and non-Hodgkin lymphoma. Among females, the five most common cancers were breast, colorectal, lung and bronchus, corpus uteri and cervix uteri. The five leading cancer deaths for males were lung and bronchus, colorectal, liver, prostate, and stomach, while for females, the five leading cancer deaths were breast, lung and bronchus, colorectal, ovary, and cervix uteri. There was a significant increase in the incidence trend of corpus uteri (AAPC<jats:inline-formula><jats:alternatives><jats:tex-math>$$:13.3$$<\/jats:tex-math><mml:math xmlns:mml=\"http:\/\/www.w3.org\/1998\/Math\/MathML\">\n                  <mml:mrow>\n                    <mml:mo>:<\/mml:mo>\n                    <mml:mn>13.3<\/mml:mn>\n                  <\/mml:mrow>\n                <\/mml:math><\/jats:alternatives><\/jats:inline-formula>) and a significant decline in the incidence trend for cervical cancer (AAPC<jats:inline-formula><jats:alternatives><jats:tex-math>$$:-4.5$$<\/jats:tex-math><mml:math xmlns:mml=\"http:\/\/www.w3.org\/1998\/Math\/MathML\">\n                  <mml:mrow>\n                    <mml:mo>:<\/mml:mo>\n                    <mml:mo>-<\/mml:mo>\n                    <mml:mn>4.5<\/mml:mn>\n                  <\/mml:mrow>\n                <\/mml:math><\/jats:alternatives><\/jats:inline-formula>) from 2011 to 2020. There was a significant increase in the mortality trend of female breast cancer from 2011 to 2015 (APC<jats:inline-formula><jats:alternatives><jats:tex-math>$$:16.3$$<\/jats:tex-math><mml:math xmlns:mml=\"http:\/\/www.w3.org\/1998\/Math\/MathML\">\n                  <mml:mrow>\n                    <mml:mo>:<\/mml:mo>\n                    <mml:mn>16.3<\/mml:mn>\n                  <\/mml:mrow>\n                <\/mml:math><\/jats:alternatives><\/jats:inline-formula>), but the trend significantly declined from 2015 to 2020 (APC<jats:inline-formula><jats:alternatives><jats:tex-math>$$:-12.5$$<\/jats:tex-math><mml:math xmlns:mml=\"http:\/\/www.w3.org\/1998\/Math\/MathML\">\n                  <mml:mrow>\n                    <mml:mo>:<\/mml:mo>\n                    <mml:mo>-<\/mml:mo>\n                    <mml:mn>12.5<\/mml:mn>\n                  <\/mml:mrow>\n                <\/mml:math><\/jats:alternatives><\/jats:inline-formula>). We also found a significant decrease in mortality trends for stomach cancer (AAPC<jats:inline-formula><jats:alternatives><jats:tex-math>$$:-4.7$$<\/jats:tex-math><mml:math xmlns:mml=\"http:\/\/www.w3.org\/1998\/Math\/MathML\">\n                  <mml:mrow>\n                    <mml:mo>:<\/mml:mo>\n                    <mml:mo>-<\/mml:mo>\n                    <mml:mn>4.7<\/mml:mn>\n                  <\/mml:mrow>\n                <\/mml:math><\/jats:alternatives><\/jats:inline-formula>) from 2011 to 2020 for both genders combined. The burden of common cancers is expected to continue to grow with ageing population, effective public health interventions targeting high burden cancers and high-risk groups, and control of modifiable risk factors will continue to be the essential approaches in reducing cancer burden.<\/jats:p>","DOI":"10.1186\/s12885-023-10962-8","type":"journal-article","created":{"date-parts":[[2023,5,22]],"date-time":"2023-05-22T06:02:08Z","timestamp":1684735328000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":14,"title":["Cancer incidence and mortality in Brunei Darussalam, 2011 to 2020"],"prefix":"10.1186","volume":"23","author":[{"given":"Elvynna","family":"Leong","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sok King","family":"Ong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Khairil Azhar","family":"Si-Ramlee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lin","family":"Naing","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2023,5,22]]},"reference":[{"issue":"3","key":"10962_CR1","doi-asserted-by":"publisher","first-page":"420","DOI":"10.1001\/jamaoncol.2021.6987","volume":"8","author":"JM Kocarnik","year":"2022","unstructured":"Kocarnik JM, Compton K, Dean FE, Fu W, Gaw BL, Harvey JD, et al. Cancer Incidence, Mortality, Years of Life Lost, Years lived with disability, and disability-adjusted life years for 29 Cancer groups from 2010 to 2019: a systematic analysis for the global burden of Disease Study 2019. JAMA Oncol. 2022;8(3):420\u201340.","journal-title":"JAMA Oncol"},{"key":"10962_CR2","doi-asserted-by":"publisher","first-page":"209","DOI":"10.3322\/caac.21660","volume":"71","author":"H Sung","year":"2021","unstructured":"Sung H, Ferlay J, Siegel RL, Laversanne M, Soerjomataram I, Jemal A, et al. Global Cancer Statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin. 2021;71:209\u201349.","journal-title":"CA Cancer J Clin"},{"key":"10962_CR3","unstructured":"Department of Policy and Planning, Ministry of Health Brunei Darussalam. Health Information Booklet 2017. 2019. Available from https:\/\/www.moh.gov.bn\/Downloadables\/Health%20Information%20Bookler%202017%20(revised%20as%20of%20January%202019).pdf. Accessed 19 May 2023."},{"issue":"1","key":"10962_CR4","first-page":"92","volume":"14","author":"SK Ong","year":"2018","unstructured":"Ong SK, Alikhan F, Lai DTC, Abdullah A, Othman K, Naing L. Population Based Lifetime Risk Estimation of Malignant Cancers in Brunei Darussalam. Brunei Int Med J. 2018;14(1):92\u2013101.","journal-title":"Brunei Int Med J"},{"key":"10962_CR5","unstructured":"Department of Economic Planning and Statistics, Ministry of Finance and Economy, Brunei Darussalam. Population. 2021. Available from https:\/\/deps.mofe.gov.bn\/SitePages\/Population.aspx. Accessed 19 May 2023."},{"key":"10962_CR6","unstructured":"World Health Organization. Country Fact Sheet. Public Health Data at a Glance. Brunei Darussalam. 2020. Available from https:\/\/www.who.int\/docs\/default-source\/wpro---documents\/countries\/brunei-darussalam\/fact-sheet-brunei-darussalam.pdf?sfvrsn=b91eddf4_5. Accessed 19 May 2023."},{"key":"10962_CR7","first-page":"73","volume":"15","author":"E Leong","year":"2019","unstructured":"Leong E, Madli F, Ong SK. Five-year survival rate of breast cancer patients in Brunei Darussalam. Brunei Int Med J. 2019;15:73\u201391.","journal-title":"Brunei Int Med J"},{"key":"10962_CR8","unstructured":"World Health Organization. International statistical classification of diseases and related health problems. 1994. 10th rev. ed. Geneva: World Health Organization."},{"key":"10962_CR9","unstructured":"Ahmad OB, Boschi-Pinto C, Lopez AD, Murray CJL, Lozano R, Inoue M. Age standardization of rates: A New WHO standard. Global Programme on Evidence Discussion Paper Series: No. 31. Geneva: World Health Organization; 2001."},{"key":"10962_CR10","doi-asserted-by":"publisher","first-page":"335","DOI":"10.1002\/(SICI)1097-0258(20000215)19:3<335::AID-SIM336>3.0.CO;2-Z","volume":"9","author":"HJ Kim","year":"2000","unstructured":"Kim HJ, Fay MP, Feuer EJ, Midthune DN. Permutation tests for joinpoint regression with applications to cancer rates. Stat Med. 2000;9:335\u201351.","journal-title":"Stat Med"},{"key":"10962_CR11","unstructured":"National Cancer Institute. Joinpoint Trend Analysis Software. 2022. Available from https:\/\/surveillance.cancer.gov\/joinpoint\/. Accessed 19 May 2023."},{"issue":"3","key":"10962_CR12","doi-asserted-by":"publisher","first-page":"345","DOI":"10.12816\/0003255","volume":"13","author":"M Furrukh","year":"2013","unstructured":"Furrukh M. Tobacco smoking and lung cancer. Sultan Qaboos Univ Med J. 2013;13(3):345\u201358.","journal-title":"Sultan Qaboos Univ Med J"},{"issue":"9","key":"10962_CR13","doi-asserted-by":"publisher","first-page":"1030","DOI":"10.1016\/S2213-2600(21)00164-8","volume":"9","author":"H Ebrahimi","year":"2021","unstructured":"Ebrahimi H, Aryan Z, Moghaddam SS, Bisignano C, Rezaei S, Pishgar F, et al. Global, regional, and national burden of respiratory tract cancers and associated risk factors from 1990 to 2019: a systematic analysis for the global burden of Disease Study 2019. The Lancet Respiratory Medicine. 2021;9(9):1030\u201349.","journal-title":"The Lancet Respiratory Medicine"},{"key":"10962_CR14","unstructured":"Ministry of Health. Brunei Darussalam Multisectoral Action Plan for the Prevention and Control of Noncommunicable Diseases (BruMAP-NCD) 2021\u20132025. 2021. Available from https:\/\/www.moh.gov.bn\/Shared%20Documents\/BRUMAP%20EXEC%20Summary%202021.pdf. Accessed 19 May 2023."},{"issue":"8","key":"10962_CR15","doi-asserted-by":"publisher","first-page":"635","DOI":"10.1177\/1010539517738072","volume":"29","author":"SK Ong","year":"2017","unstructured":"Ong SK, Lai DTCL, Wong JYY, Si-Ramlee KA, Razak LA, Kassim N, et al. Cross-sectional STEPwise approach to surveillance (STEPS) population survey of noncommunicable diseases (NCD) and risk factors in Brunei Darussalam 2016. Asia Pac J Public Health. 2017;29(8):635\u201348.","journal-title":"Asia Pac J Public Health"},{"issue":"3","key":"10962_CR16","doi-asserted-by":"publisher","first-page":"258","DOI":"10.1016\/j.maturitas.2014.12.017","volume":"80","author":"R Baena","year":"2015","unstructured":"Baena R, Salinas P. Diet and colorectal cancer. Maturitas. 2015;80(3):258\u201364.","journal-title":"Maturitas"},{"key":"10962_CR17","doi-asserted-by":"publisher","first-page":"481","DOI":"10.1016\/j.asjsur.2016.07.005","volume":"40","author":"SK Veetil","year":"2016","unstructured":"Veetil SK, Lim KG, Chaiyakunapruk N, Ching SM, Hassan MRA. Colorectal cancer in Malaysia: its burden and implications for a multiethnic country. Asian J Surg. 2016;40:481\u20139.","journal-title":"Asian J Surg"},{"issue":"7","key":"10962_CR18","doi-asserted-by":"publisher","first-page":"627","DOI":"10.1016\/S2468-1253(22)00044-9","volume":"7","author":"R Sharma","year":"2022","unstructured":"Sharma R, Abbasi-Kangevari M, Abd-Rabu R, Abidi H, Abu-Gharbieh E, Acuna JM, et al. Global, Regional, and national burden of colorectal cancer and its risk factors, 1990\u20132019: a systematic analysis for the global burden of Disease Study 2019. Lancet Gastroenterol Hepatol. 2022;7(7):627\u201347.","journal-title":"Lancet Gastroenterol Hepatol"},{"issue":"1","key":"10962_CR19","doi-asserted-by":"publisher","first-page":"259","DOI":"10.31557\/APJCP.2020.21.1.259","volume":"21","author":"E Leong","year":"2020","unstructured":"Leong E, Ong SK, Madli F, Tan A, Lai D, Basir N, et al. Survival rates and associated factors of colorectal cancer patients in Brunei Darussalam. Asian Pac J Cancer Prev. 2020;21(1):259\u201365.","journal-title":"Asian Pac J Cancer Prev"},{"key":"10962_CR20","first-page":"151","volume":"11","author":"Z Momenimovahed","year":"2019","unstructured":"Momenimovahed Z, Salehiniya H. Epidemiological characteristics of and risk factors for breast cancer in the world. Breast cancer (Dove Medical Press). 2019;11:151\u201364.","journal-title":"Breast cancer (Dove Medical Press)"},{"key":"10962_CR21","doi-asserted-by":"publisher","first-page":"1198","DOI":"10.1111\/imj.12256","volume":"43","author":"J Hayes","year":"2013","unstructured":"Hayes J, Richardson A, Frampton. Population attributable risks for modifiable lifestyle factors and breast cancer in New Zealand women. Intern Med J. 2013;43:1198\u2013204.","journal-title":"Intern Med J"},{"key":"10962_CR22","doi-asserted-by":"publisher","first-page":"140","DOI":"10.1186\/s13045-019-0828-0","volume":"12","author":"N Li","year":"2019","unstructured":"Li N, Deng Y, Zhou L, Tian T, Yang S, Wu Y, et al. Global burden of breast cancer and attributable risk factors in 195 countries and territories, from 1990 to 2017: results from the global burden of Disease Study 2017. J Hematol Oncol. 2019;12:140.","journal-title":"J Hematol Oncol"},{"key":"10962_CR23","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1016\/j.breast.2022.08.010","volume":"66","author":"M Arnold","year":"2022","unstructured":"Arnold M, Morgan E, Rumgay H, Mafra A, Singh D, Laversanne M, et al. Current and future burden of breast cancer: global statistics for 2020 and 2040. THE BREAST. 2022;66:15\u201323.","journal-title":"THE BREAST"},{"issue":"10","key":"10962_CR24","doi-asserted-by":"publisher","first-page":"e02588","DOI":"10.1016\/j.heliyon.2019.e02588","volume":"5","author":"LL Chaw","year":"2019","unstructured":"Chaw LL, Lim STW, Yussof SRM. Human papillomavirus vaccine coverage among female students in Brunei Darussalam: results from the first 4 years of the national school-based vaccination programme. Heliyon. 2019;5(10):e02588.","journal-title":"Heliyon"},{"key":"10962_CR25","unstructured":"World Health Organization. Global strategy to accelerate the elimination of cervical cancer as a public health problem. Geneva: World Health Organization; 2020. Licence: CC BY-NC-SA 3.2 IGO. Available from https:\/\/www.who.int\/publications\/i\/item\/9789240014107. Accessed 19 May 2023."},{"key":"10962_CR26","doi-asserted-by":"publisher","first-page":"354","DOI":"10.1093\/jnci\/djx214","volume":"110","author":"J Lortet-Tieulent","year":"2018","unstructured":"Lortet-Tieulent J, Ferlay J, Bray F, Jemal A. International patterns and trends in endometrial cancer incidence, 1978\u20132013. J Natl Cancer Inst. 2018;110:354\u201361.","journal-title":"J Natl Cancer Inst"},{"issue":"Suppl 2","key":"10962_CR27","doi-asserted-by":"publisher","first-page":"37","DOI":"10.1002\/ijgo.12612","volume":"143","author":"F Amant","year":"2018","unstructured":"Amant F, Mirza MR, Koskas M, Creutzberg CL. Cancer of the corpus uteri. Int J Gynaecol Obstet. 2018;143(Suppl 2):37\u201350.","journal-title":"Int J Gynaecol Obstet"},{"key":"10962_CR28","unstructured":"Wild CP, Weiderpass E, Stewart BW, editors. World Cancer Report: Cancer Research for Cancer Prevention. Lyon, France: International Agency for Research on Cancer; 2020. Available from: http:\/\/publications.iarc.fr\/586. Accessed 19 May 2023."},{"key":"10962_CR29","doi-asserted-by":"publisher","first-page":"1285","DOI":"10.1002\/pros.20419","volume":"66","author":"SK Park","year":"2006","unstructured":"Park SK, Sakoda LC, Kang D, Chokkalingam AP, Lee E, Shin HR, et al. Rising prostate cancer rates in South Korea. Prostate. 2006;66:1285\u201391.","journal-title":"Prostate"},{"key":"10962_CR30","doi-asserted-by":"publisher","first-page":"222","DOI":"10.1186\/1471-2407-12-222","volume":"12","author":"C Chen","year":"2012","unstructured":"Chen C, Naidoo N, Yang Q, Hartman M, Verkooijen HM, Loy EY, et al. A comparative population-based study of prostate cancer incidence and mortality rates in Singapore, Sweden and Geneva, Switzerland from 1973 to 2006. BMC Cancer. 2012;12:222.","journal-title":"BMC Cancer"},{"key":"10962_CR31","doi-asserted-by":"publisher","first-page":"390","DOI":"10.1093\/jjco\/hyv002","volume":"45","author":"K Katanoda","year":"2015","unstructured":"Katanoda K, Hori M, Matsuda T, Shibata A, Nishino Y, Hattori M. An updated report on the trends in cancer incidence and mortality in Japan, 1958\u20132013. Jpn J Clin Oncol. 2015;45:390\u2013401.","journal-title":"Jpn J Clin Oncol"},{"key":"10962_CR32","doi-asserted-by":"publisher","first-page":"106","DOI":"10.1159\/000360206","volume":"37","author":"F Zhao","year":"2014","unstructured":"Zhao F, Xu Y, Yang K, Liu M, Wei D, Zhang Y. THADA gene polymorphism and prostate cancer risk: a meta-analysis. Oncol Res Treat. 2014;37:106\u201310.","journal-title":"Oncol Res Treat"},{"issue":"3","key":"10962_CR33","doi-asserted-by":"publisher","first-page":"458","DOI":"10.1001\/jamaoncol.2020.7600","volume":"7","author":"Z Bakouny","year":"2021","unstructured":"Bakouny Z, Paciotti M, Schmidt AL, Lipsitz SR, Choueiri TK, Trinh Q-D. Cancer screening tests and cancer diagnoses during the COVID-19 pandemic. JAMA Oncol. 2021;7(3):458. https:\/\/doi.org\/10.1001\/jamaoncol.2020.7600.","journal-title":"JAMA Oncol"},{"key":"10962_CR34","first-page":"59","volume":"2","author":"JA Cruz","year":"2007","unstructured":"Cruz JA, Wishart DS. Applications of machine learning in cancer prediction and prognosis. Cancer Inf. 2007;2:59\u201377.","journal-title":"Cancer Inf"},{"key":"10962_CR35","doi-asserted-by":"publisher","first-page":"75","DOI":"10.1186\/s13058-019-1158-4","volume":"21","author":"C Ming","year":"2019","unstructured":"Ming C, Viassolo V, Probst-Hensch N, Chappuis PO, Dinov ID, Katapodi MC. Machine learning techniques for personalized breast cancer risk prediction: comparison with the BCRAT and BOADICEA models. Breast Cancer Res. 2019;21:75.","journal-title":"Breast Cancer Res"},{"issue":"9","key":"10962_CR36","doi-asserted-by":"publisher","first-page":"2945","DOI":"10.31557\/APJCP.2021.22.9.2945","volume":"22","author":"L Gatellier","year":"2021","unstructured":"Gatellier L, Ong SK, Matsuda T, Ramlee N, Lau FN, Yusak S, et al. Preparing for the next pandemic: an Asian National Cancer Centers Alliance (ANCCA) Initiative. Asian Pac J Cancer Prev. 2021;22(9):2945\u201350. https:\/\/doi.org\/10.31557\/APJCP.2021.22.9.2945.","journal-title":"Asian Pac J Cancer Prev"}],"container-title":["BMC Cancer"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12885-023-10962-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12885-023-10962-8\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12885-023-10962-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,5,22]],"date-time":"2023-05-22T06:03:24Z","timestamp":1684735404000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmccancer.biomedcentral.com\/articles\/10.1186\/s12885-023-10962-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,5,22]]},"references-count":36,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2023,12]]}},"alternative-id":["10962"],"URL":"https:\/\/doi.org\/10.1186\/s12885-023-10962-8","relation":{},"ISSN":["1471-2407"],"issn-type":[{"value":"1471-2407","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,5,22]]},"assertion":[{"value":"6 March 2023","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"14 May 2023","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"22 May 2023","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Ethical approval for this study was obtained from the Medical and Health Research Ethics Committee of the Ministry of Health, Brunei Darussalam [Ref: MHREC\/MOH\/2022\/1(1)]. This study did not involve any patient contact. Participants\u2019 anonymity is preserved as data were de-identified. Formal approval was obtained from the Director of Policy and Planning, Ministry of Health and the Director General of Medical and Health Services, Ministry of Health, Brunei Darussalam before the study commenced. All methods were carried out in accordance with relevant guidelines and regulations.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"466"}}